Name | Benzamide Derivative 1 |
---|
Description | Benzamide Derivative 1 is a benzamide derivative from patent EP0213775A1, compound 18. Benzamide Derivative 1 may be useful in treatment of gastrointestinal disorders. |
---|---|
Related Catalog | |
Target |
Dopamine, mACh receptor[1] |
In Vitro | Substituted benzamides have been shown to possess a number of pharmacological properties most of which are related to their ability to antagonize the central and peripheral effects of dopamine and/or facilitate the release of acetylcholine on to muscarinic receptors in the gastrointestinal smooth muscle. This has led to their successful clinical use as antiemetic and in the treatment of a wide range of gastrointestinal disorders of somatic, psychosomatic and iatrogenic origin[1]. |
References |
Molecular Formula | C22H34ClN3O3 |
---|---|
Molecular Weight | 423.98 |